Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as talotrexin, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase I trial is studying side effects, best way to give, and best dose of
talotrexin in treating patients with advanced or recurrent solid tumors.